Clin Psychopharmacol Neurosci.  2017 Aug;15(3):285-287. 10.9758/cpn.2017.15.3.285.

Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report

Affiliations
  • 1Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Messina, Messina, Italy. mlamberti@unime.it, marcolb@yahoo.it
  • 2Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Abstract

In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.

Keyword

Antipsychotics; Drug side effects; Tardive dyskineisa; Movement disorders; Pediatrics

MeSH Terms

Antipsychotic Agents
Aripiprazole
Biperiden*
Drug-Related Side Effects and Adverse Reactions
Dyskinesias
Female*
Humans
Intellectual Disability
Long Term Adverse Effects
Mood Disorders
Movement Disorders*
Pediatrics
Problem Behavior
Antipsychotic Agents
Aripiprazole
Biperiden
Full Text Links
  • CPN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr